Psychedelic Research in Science & Medicine (PRISM) is a DGR-1 charity, established in 2011 to initiate, coordinate, and support formal research into the applications of medicinal psychedelics and related technologies. PRISM provides scientific expertise for clinical trial and technology development for medicinal psychedelics and consciousness research. PRISM supports clinical research for the treatment and prevention of conditions for which current therapies provide limited relief.
Here at PRISM we have been dedicated for the last decade to supporting research into the therapeutic potential of psychedelic-assisted therapy. Our team has vast experience in clinical trial development, science communication, harm reduction and social benefit development.
PRISM’s medicinal psychedelic research program seeks to develop evidence-based treatments that reduce suffering, enhance our understanding of disease mechanisms, and illuminate the study of consciousness itself.
World Ayahuasca Conference 2019